Automated quantitative breakdown of fundamental strengths between DRREDDY and LUPIN.
| Financial Metric | DRREDDY | LUPIN |
|---|---|---|
| Valuation Multiples | ||
| Market Capitalization | ₹97,085 Cr | ₹95,797 Cr |
| Price to Earnings (P/E) | 30.49 | 16.83 |
| Price to Book (P/B) | 2.72 | 3.18 |
| Profitability & Capital Efficiency | ||
| Return on Capital Employed (ROCE) | 10.39% | 31.14% |
| Return on Equity (ROE) | 21.61% | 16.19% |
| Operating Profit Margin (OPM) | 13.42% | 26.45% |
| Net Profit Margin (NPM) | 2.94% | 33.36% |
| Balance Sheet & Solvency | ||
| Debt to Equity Ratio | 0.22 | 0.04 |
| Dividend Yield | 4.73% | 4.38% |
| Historical Growth | ||
| 3-Year Sales Growth (CAGR) | -18.49% | 28.20% |
| Latest Quarter Financial Results | ||
| Quarterly Revenue (30 Jun 2026) | ₹8,071 Cr | ₹8,217 Cr |
| Quarterly Net Profit | ₹444 Cr | ₹1,415 Cr |
Dr. Reddy's Laboratories vs Sun Pharmaceutical Industries
DRREDDY vs CIPLADr. Reddy's Laboratories vs Cipla Limited
LUPIN vs CIPLALupin Limited vs Cipla Limited
LUPIN vs SUNPHARMALupin Limited vs Sun Pharmaceutical Industries
APOLLOHOSP vs MAXHEALTHApollo Hospitals Enterprise vs Max Healthcare Institute
MAXHEALTH vs FORTISMax Healthcare Institute vs Fortis Healthcare